Perceptive Advisors LLC Corrects and Reports 9.99% Stake in Kiora Pharmaceuticals

Perceptive Advisors LLC, along with Joseph Edelman and Perceptive Life Sciences Master Fund, Ltd., has filed a Schedule 13G reporting a 9.99% stake in Kiora Pharmaceuticals, Inc. (KPRX). This filing, dated August 10, 2026, serves as a corrected restatement of an original filing from April 2026 that was inadvertently submitted under an incorrect CIK number. The reporting persons beneficially own 442,387 shares of common stock. This total includes 438,471 shares held directly by the Master Fund and 3,916 shares issuable upon the exercise of warrants. Although the Master Fund holds pre-funded and common warrants for over 9 million additional shares, exercise is strictly limited by a 9.99% beneficial ownership cap. Perceptive Advisors serves as the investment manager to the Master Fund, and Joseph Edelman is the managing member of Perceptive Advisors. The filing confirms that these securities were acquired for investment purposes and not to influence or change the control of the issuer.